USPTO trademark

ONZARVIQ

Under examinationUSPTOWord markClass 5

"ONZARVIQ" is a word mark owned by Celgene Corporation, filed at the USPTO on June 8, 2026. It is under examination and covers class 5 (Pharmaceuticals).

View Celgene Corporation portfolioGet this data via the API
Official USPTO record
ONZARVIQ trademark as filed
As filed with the USPTO
Status
Under examination
Since October 17, 2026
Filed
June 8, 2026
Registered
Not yet
Expires
Not recorded
Application no.
99871326
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
1 class
Ownership

Who owns ONZARVIQ

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Celgene Corporation

Princeton, United States

848 trademarks in the portfolioView company

Representative

Marilyn F. Kelly

Bristol-Myers Squibb Company

Goods and services

What the mark covers

The products and services ONZARVIQ is filed for, grouped by Nice class.

  • Pharmaceutical preparations for the treatment and prevention of obesity, cardiovascular diseases, central nervous system diseases, metabolic disorders, stroke, cancer, inflammatory diseases, respiratory diseases, infectious diseases, auto-immune diseases, solid organ transplant rejection, autoinflammatory disease, blood disease, multiple sclerosis, ulcerative colitis, cystic fibrosis, arthritis, Alzheimer’s disease, autism spectrum disorder and musculoskeletal and skin disease; Antivirals; Antibodies for medical purposes; Biological preparations for the treatment of cancer; Anticoagulants; Stem cells for medical purposes; Radiopharmaceutical preparations for the treatment of cancer and solid tumors; Diagnostic radiopharmaceutical preparations; Diagnostic preparations for medical purposes

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Notification of non-final action e-mailed
  2. Non-final action e-mailed
  3. Non-final action written
  4. Assigned to examiner
  5. New application office supplied data entered
  6. Application filing receipt mailed
  7. New application entered
FAQ

About ONZARVIQ

Who owns the trademark "ONZARVIQ"?

The USPTO trademark "ONZARVIQ" (application 99871326) is owned by Celgene Corporation.

What is the status of "ONZARVIQ"?

Its status at the USPTO is: under examination.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull ONZARVIQ and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019eaff9-0f31-74bd-bd57-dc97c6a29cfd
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019eaff9-0f31-74bd-bd57-dc97c6a29cfd",
  "object": "trademark",
  "mark_text": "ONZARVIQ",
  "status": {
    "primary": "pending",
    "stage": "examining"
  },
  "office_code": "US",
  "application_number": "99871326",
  "filing_date": "2026-06-08",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "Celgene Corporation",
      "entity_id": "ent_019f2866-8569-72d2-83e9-d3795e77d57d"
    }
  ]
}